[CLS] O
The O
investigations O
were O
performed O
on O
the O
blood O
and O
urine O
of O
400 O
subjects O
: O
300 O
male O
copper B
smelters O
and O
100 O
nonexposed O
male O
subjects O
. O
[SEP] O

[CLS] O
Although O
mercury B
is O
clearly O
toxic O
to O
most O
mammalian O
organ O
systems O
, O
especially O
the O
immune O
system O
, O
exposure O
has O
still O
increased O
in O
some O
areas O
of O
the O
world O
. O
[SEP] O

[CLS] O
The O
aim O
of O
the O
present O
study O
is O
to O
determine O
the O
levels O
of O
PCAHs B
in O
samples O
of O
meat O
, O
fish O
, O
chicken O
, O
fried O
potato O
, O
and O
toasted O
bread O
, O
which O
will O
be O
thermally O
processed O
using O
conventional O
and O
microwave O
ovens O
. O
[SEP] O

[CLS] O
The O
present O
study O
aims O
to O
demonstrate O
the O
effect O
of O
a O
fungicide O
, O
Thiovit B
( O
( O
R O
) O
) O
Jet O
on O
the O
structure O
of O
epidermal O
microtrichia O
( O
trichome O
) O
of O
the O
dorsal O
thorax O
in O
Drosophila O
melanogaster O
. O
[SEP] O

[CLS] O
The O
prepared O
total O
and O
PEs O
of O
the O
plant O
samples O
were O
tested O
using O
MTT B
( O
3 B
- I
( I
4 I
, I
5 I
- I
dimethylthiazol I
- I
2yl I
) I
- I
2 I
, I
5 I
- I
diphenyltetrazolium I
bromide I
) O
assay O
on O
the O
splenocytes O
with O
or O
without O
stimulation O
by O
concanavalin O
- O
A O
( O
Con O
- O
A O
) O
, O
a O
mitogenic O
agent O
used O
as O
positive O
control O
. O
[SEP] O

[CLS] O
A O
simple O
and O
accurate O
analytical O
method O
was O
developed O
for O
simultaneous O
quantification O
of O
three O
steroidal B
saponins I
in O
the O
roots O
of O
Ophiopogon O
japonicus O
via O
high O
- O
performance O
liquid O
chromatography O
( O
HPLC O
) O
with O
mass O
spectrometry O
( O
MS O
) O
in O
this O
study O
. O
[SEP] O

[CLS] O
The O
most O
abundant O
contents O
were O
4a B
alpha I
, I
7 I
beta I
, I
7a I
alpha I
- I
nepetalactone I
( O
18 O
. O
10 O
% O
) O
, O
germacrene B
( O
15 O
. O
68 O
% O
) O
and O
elemol B
( O
14 O
. O
38 O
% O
) O
. O
[SEP] O

[CLS] O
The O
utilized O
dose O
of O
Al B
was O
1 O
/ O
50 O
LD50 O
( O
0 O
. O
07 O
g O
Al B
/ O
kg O
b O
. O
wt O
. O
) O
. O
[SEP] O

[CLS] O
Although O
RAP B
, O
used O
alone O
, O
had O
little O
effect O
on O
myc O
protein O
expression O
, O
when O
combined O
with O
a O
MNK O
inhibitor O
, O
myc O
protein O
expression O
was O
abrogated O
. O
[SEP] O

[CLS] O
This O
work O
deals O
with O
optimisation O
of O
adventitious O
root O
suspension O
culture O
of O
Withania O
somnifera O
( O
L O
. O
) O
Dunal O
( O
Solanaceae O
) O
for O
the O
production O
of O
biomass O
and O
withanolide B
A I
and O
we O
investigated O
the O
effect O
of O
carbon B
source O
and O
the O
initial O
medium O
pH O
on O
growth O
and O
production O
of O
withanolide B
A I
in O
adventitious O
root O
cultures O
of O
Withania O
somnifera O
. O
[SEP] O

[CLS] O
Scanning O
electron O
microscopy O
revealed O
a O
relationship O
between O
the O
rate O
of O
IVM B
release O
and O
the O
surface O
porosity O
of O
the O
implants O
, O
release O
being O
higher O
as O
implant O
porosity O
increased O
. O
[SEP] O

[CLS] O
These O
iridoid B
glucosides I
were O
found O
to O
be O
inactive O
against O
acetyl B
and O
butyrylcholinesteras O
but O
active O
against O
lipoxygenase O
. O
[SEP] O

[CLS] O
Differentiating O
the O
roles O
of O
mGlu2 O
and O
mGlu3 O
receptors O
using O
LY541850 B
, O
an O
mGlu2 O
agonist O
/ O
mGlu3 O
antagonist O
. O
[SEP] O

[CLS] O
The O
GC O
- O
MS O
analysis O
of O
chloroform B
extracts O
has O
shown O
the O
presence O
of O
compounds O
like O
eicosane B
, O
oleic B
acid I
, O
stigmasterol B
and O
vitamin B
E I
. O
[SEP] O

[CLS] O
Several O
variables O
were O
investigated O
: O
gonado O
- O
somatic O
index O
( O
GSI O
) O
, O
liver O
- O
somatic O
index O
( O
LSI O
) O
; O
7 B
- I
ethoxyresorufin I
- O
O B
- O
deethylase O
( O
EROD O
) O
, O
benzo B
( I
a I
) I
pyrene I
monooxygenase O
and O
acetylcholinesterase O
activities O
; O
glutathione B
( O
GSH B
) O
, O
testosterone B
, O
17 B
beta I
- I
estradiol I
, O
total O
lipid O
, O
phospholipid O
( O
PL O
) O
and O
triglyceride B
contents O
. O
[SEP] O

[CLS] O
Although O
some O
of O
the O
physicochemical O
and O
biopharmaceutical O
properties O
of O
IMC B
are O
already O
known O
, O
in O
order O
to O
establish O
a O
feasible O
comparison O
between O
IMC B
and O
F B
- I
IMC I
, O
the O
behavior O
of O
the O
former O
was O
also O
investigated O
in O
the O
same O
conditions O
as O
for O
F B
- I
IMC I
. O
[SEP] O

[CLS] O
mGlu5R O
promotes O
glutamate B
AMPA B
receptor O
phosphorylation O
via O
activation O
of O
PKA O
/ O
DARPP O
- O
32 O
signaling O
in O
striatopallidal O
medium O
spiny O
neurons O
. O
[SEP] O

[CLS] O
This O
article O
is O
part O
of O
a O
Special O
Issue O
entitled O
' O
Metabotropic O
Glutamate B
Receptors O
' O
. O
[SEP] O

[CLS] O
Participants O
inhaled O
air O
7 O
. O
5 O
% O
CO B
( I
2 I
) I
for O
20 O
minutes O
( O
single O
- O
blind O
presentation O
) O
, O
and O
a O
non O
- O
blinded O
single O
vital O
capacity O
of O
35 O
% O
CO B
( I
2 I
) I
. O
[SEP] O

[CLS] O
These O
findings O
suggest O
that O
mGlu O
( O
8 O
) O
may O
partially O
mediate O
the O
antiparkinsonian O
effects O
of O
group O
III O
mGlu O
agonists O
in O
animal O
models O
of O
PD O
in O
which O
dopamine B
depletion O
or O
blockade O
of O
D O
( O
2 O
) O
- O
like O
dopamine B
receptors O
is O
prolonged O
and O
indicate O
that O
selective O
activation O
of O
mGlu O
( O
8 O
) O
may O
represent O
a O
novel O
therapeutic O
strategy O
for O
alleviating O
the O
motor O
symptoms O
of O
PD O
. O
[SEP] O

[CLS] O
These O
results O
provide O
initial O
evidence O
of O
a O
GABAA O
alpha O
5 O
deficit O
in O
ASD O
and O
support O
further O
investigations O
of O
the O
GABA B
system O
in O
this O
disorder O
. O
[SEP] O

[CLS] O
CIBYL1 O
, O
along O
with O
five O
known O
compounds O
, O
pimprinine B
( O
2 O
) O
, O
( B
3R I
, I
4S I
, I
5R I
, I
6R I
) I
- I
3 I
, I
4 I
, I
5 I
, I
6 I
- I
tetrahydro I
- I
4 I
- I
hydroxy I
- I
3 I
, I
5 I
, I
6 I
- I
trimethyl I
- I
2H I
- I
pyran I
- I
2 I
- I
one I
( O
3 O
) O
, O
indolyl B
- I
3 I
- I
carboxylic I
acid I
( O
4 O
) O
, O
2 B
- I
phenylacetamide I
( O
5 O
) O
and O
di B
( I
1H I
- I
pyrrol I
- I
2 I
- I
yl I
) I
methanone I
( O
6 O
) O
. O
[SEP] O

